M. Janvier

发表

Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group.

T. Delozier, J. Petit, B. Weber, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Delayed adjuvant tamoxifen: ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial)

M. Héry, T. Delozier, M. Namer, 2000, Annals of Oncology.

Dexamethasone+Thalidomide (Dex/Thal) Compared to VAD as a Pre-Transplant Treatment in Newly Diagnosed Multiple Myeloma (MM): A Randomized Trial.

S. Chevret, M. Macro, V. Leblond, 2006 .

High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?

T. Delozier, P. Viens, J. Moatti, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)

T. Delozier, V. Bardou, P. Viens, 1999, British Journal of Cancer.

Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

H. Dombret, A. Vekhoff, P. Cony-Makhoul, 1999, Leukemia.

R. Berger, R. Berger, M. Sanz, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

T. Molina, F. Jardin, G. Salles, 2011, The Lancet.

A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes

E. Solary, E. Wattel, P. Fenaux, 1999, Leukemia.

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial

T. Molina, F. Jardin, G. Salles, 2011, The Lancet.

Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer.

C. Gisselbrecht, É. Lepage, J. Lotz, 1996, Bone marrow transplantation.

Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS.

E. Solary, H. Tilly, E. Wattel, 1999, Advances in experimental medicine and biology.

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance

J. Cayuela, H. Dombret, A. Delannoy, 2010 .

Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia

H. Tilly, C. Gardin, E. Archimbaud, 1993 .

195 Autologous bone marrow (ABMT) or peripheral blood stem cell (ABSCT) transplantation after intensive chemotherapy in myelodysplastic syndromes (MDS)

A. Stamatoullas, E. Solary, P. Fenaux, 1997 .

Intensive Therapy of Myelodysplastic Syndromes and Secondary Leukemias: Preliminary Findings of the French Experience

E. Solary, H. Tilly, E. Wattel, 1997 .

Original Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: A GELA study

R. Bouabdallah, N. Brousse, C. Haioun, 2005 .

Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

R. Bouabdallah, N. Brousse, C. Sebban, 2002, Leukemia.

Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.

H. Tilly, C. Gardin, E. Archimbaud, 1993, Blood.

Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia.

A. Baruchel, G. Leverger, J. Reiffers, 1992, Blood.

Fractionated Doses of Gemtuzumab Ozogamicin (GO) Combined to Standard Chemotherapy (CT) Improve Event-Free and Overall Survival in Newly-Diagnosed De Novo AML Patients Aged 50–70 Years Old: A Prospective Randomized Phase 3 Trial From the Acute Leukemia French Association (ALFA)

H. Dombret, S. Chevret, C. Preudhomme, 2011 .

Randomized Comparison of Standard Induction with Daunorubicin (DNR) for 3 Days vs Idarubicin (IDA) for 3 or 4 Days in AML pts Aged 50 to 70 and of Maintenance with Interleukin 2. Final Analysis of the ALFA 9801 Study.

J. Bourhis, H. Dombret, S. Chevret, 2007 .

Pulmonary toxicity of chemotherapy and GM-CSF.

L. Couderc, I. Caubarrere, M. Janvier, 1994, Respiratory medicine.

[Leukemia and pre-leukemic conditions occurring after treatment of breast cancer].

J. Julien, P. Kerbrat, H. Lauche, 2000, Presse medicale.

Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients.

J. Blay, W. Brugger, P. Viens, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous hematopoietic stem cell transplantation in elderly patients (≥ 70 years) with non-Hodgkin's lymphoma: A French Society of Bone Marrow Transplantation and Cellular Therapy retrospective study.

R. Bouabdallah, B. Drénou, P. Biron, 2015, Journal of geriatric oncology.

Short term vs lifelong adjuvant tamoxifen in early breast cancer (EBC): A randomized trial (TAM-01)

T. Delozier, J. Petit, B. Weber, 1997 .

A Prospective Randomized Study Comparing Dose Intensive Immunochemotherapy with R-ACVBP vs Standard R-CHOP In Younger Patients with Diffuse Large B-Cell Lymphoma (DLBCL). Groupe d'Etude Des Lymphomes De l'Adulte (GELA) Study LNH03-2B

T. Molina, F. Jardin, B. Coiffier, 2010 .

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Marc C. Jacob, M. Boubaya, J. Rossi, 2020, Leukemia.

[Intensive chemotherapy and autograft of hematopoietic stem cells in the treatment of metastatic cancer: results of the national protocol Pegase 04].

B. Asselain, C. Gisselbrecht, J. Lotz, 1999, Hematology and Cell Therapy.

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

N. Mounier, P. Chérel, M. Janvier, 2005, Clinical lymphoma.

Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma

B. Asselain, M. Tulliez, J. Vilcoq, 2006, Hematological oncology.

Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.

H. Dombret, H. Tilly, S. Chevret, 2004, Blood.

Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

K. Hoang-Xuan, M. Sanson, O. Casasnovas, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Treatment of chronic idiopathic thrombopenic purpura with intravenous immunoglobulins].

J. Clauvel, M. Janvier, 1983, Presse medicale.

Traitement du purpura thrombopénique idiopathique par immunoglobulines intraveineuses

M. Boiron, J. Clauvel, G. Schaison, 1983 .

Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment

H. Jouault, F. Beaujean, M. Janvier, 1998, Bone Marrow Transplantation.

Essential thrombocythemias. Clinical evolutionary and biological data

R. Berger, M. Boiron, G. Flandrin, 1986, Cancer.

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

F. Jardin, P. Gaulard, B. Coiffier, 2011, The Lancet. Oncology.

Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs: A Randomized, Controlled Trial

D. Blaise, I. Philip, J. Michon, 1997, Annals of Internal Medicine.

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol.

T. Delozier, B. Asselain, C. Gisselbrecht, 2005, European journal of cancer.

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.

P. Ravaud, S. Chevret, X. Mariette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA

G. Salles, O. Casasnovas, P. Feugier, 2011, Haematologica.

Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma

K. Hoang-Xuan, S. Choquet, C. Soussain, 2011, Journal of Neuro-Oncology.

Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, R. Bouabdallah, H. Tilly, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

ABVD or BEACOPPbaseline along with involved-field radiotherapy in early-stage Hodgkin Lymphoma with risk factors: Results of the European Organisation for Research and Treatment of Cancer (EORTC)-Groupe d'Étude des Lymphomes de l'Adulte (GELA) H9-U intergroup randomised trial.

J. Raemaekers, G. Salles, D. de Jong, 2017, European journal of cancer.

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study

J. Cayuela, H. Dombret, A. Delannoy, 2012 .

Acute monoblastic leukaemia. Clinical, biological data and survival in 45 cases.

M. Marty, M. Boiron, A. Bernheim, 2009, Scandinavian journal of haematology.

Deterioration of quality of life of high-risk breast cancer patients treated with high-dose chemotherapy: the PEGASE 01 Quality of Life Study.

T. Delozier, D. Spaeth, P. Biron, 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?

T. Delozier, P. Viens, L. Molinier, 2012, PharmacoEconomics (Auckland).

[Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae].

C. Leport, C. Perronne, J. Vildé, 1993, Presse medicale.

A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia.

A. Baruchel, G. Leverger, J. Reiffers, 1992, Journal of Autoimmunity.

Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.

P. Cony-Makhoul, C. Patte, A. Delmer, 1995, Blood.

Pharmacokinetics of Dasatinib as a First Line Therapy In Newly Diagnosed CML Patients (OPTIM dasatinib trial): Correlation with Safety and Response.

L. Busque, P. Rousselot, F. Mahon, 2010 .

[Use of Ommaya reservoirs in the treatment of meningeal relapse of acute lymphoblastic leukemia].

G. Leverger, M. Boiron, G. Tobelem, 1984, Nouvelle revue francaise d'hematologie.

[Use of high-dose intravenous gamma globulins in the treatment of autoimmune hemolytic anemia].

A. Bussel, M. Janvier, C. Traullé, 1983, Presse medicale.